Home/MIRA Pharmaceuticals/Ned Macpherson

NM

Ned Macpherson

Director

MIRA Pharmaceuticals

Roles

DirectoratMIRA Pharmaceuticals

DirectoratTelomir Pharmaceuticals

Therapeutic Areas

Neurology Psychiatry

MIRA Pharmaceuticals Pipeline

Drug	Indication	Phase
Ketamir-2 (Ketamir)	Neuropathic Pain (NP)	Phase 1
MIRA-55	Anxiety & Cognitive Decline (e.g., early-stage dementia)	Preclinical

Leadership Team at MIRA Pharmaceuticals

Chairman of the Board and Chief Executive Officer

Matthew Del Giudice

Denil N. Shekhat

Chief Scientific Advisor

View full MIRA Pharmaceuticals profile